Low Radiation Scans Detect Very Early Lung Cancer

by U.S. Medicine

November 6, 2013

PHILADELPHIA – Low-dose computed tomography (LDCT) can be extremely valuable for identifying tiny lung nodules which can indicate the earliest stages of lung cancer, according to a study of veterans at high risk of the disease.1

The study, presented this spring at the American Thoracic Society (ATS) 2013 International Conference in Philadelphia, noted that LDCT uses less than a quarter of the radiation of a conventional computed tomography (CT) scan.

“Lung cancer is the leading cause of cancer-related death and has a poor survival rate,” said Sue Yoon, FNP, nurse practitioner at VA Boston Healthcare West Roxbury Division. “Most of our veterans in these ages have a heavy smoking history, and early screening is desirable to improve outcomes. Our study was undertaken to learn how often we would discover significant abnormalities and how to adapt our existing processes and interdisciplinary approaches to accommodate additional patients.”

The National Lung Cancer Screening Trial (NLST) found that LDCT resulted in a 20% reduction of lung cancer mortality compared with chest X-ray among heavy smokers aged 55 to 74 years.

The Boston study involved 56 patients, median age 61 to 65 years, with a smoking history of more than 30 pack years or of 20 pack years and one additional cancer risk factor, such as occupational exposure to carcinogens or personal or family history of cancer or chronic obstructive pulmonary disease (COPD).

Based on the LDCT scans, of each patient, the researchers found that 31 patients had a nodule of 4 mm or larger or another abnormal opacity, of which six were deemed suspicious for malignancy. The study also found that 34 patients had more than one nodule, with four patients  diagnosed with biopsy-proven lung cancer.

 “Our preliminary rate of lung cancer diagnosis after the first round of screening was 7%, which was significantly higher than NLST group, which had a preliminary rate of 3.8 percent at its first round,” Yoon said. “In addition, detection of nodules larger than 4 mm was 55% in our group compared with 27% in the NLST group.”

She suggested three reasons for the difference in nodule prevalence rates between the current study and the NLST:

  • The Boston VA study had much smaller numbers than the multicenter NLST;
  • The scanning technology used during the current trial had advanced since the earlier NLST trial was conducted;
  • The VA population was predominantly male and most patients had COPD, unlike the NLST study.

“Our previous experience with diagnosing and managing a high volume of incidentally discovered pulmonary nodules suggested that a low dose CT scan screening program, in which patients are screened annually, could be a substantial undertaking,” Yoon said. “Considerable effort goes into each step of the process: selecting patients, tracking abnormalities, further selecting patients with suspicious abnormalities for additional diagnostic and therapeutic interventions.

“Although we plan to continue and expand the LDCT screening program, this will require additional planning and, potentially, resources,” she added. “Currently we are using a gatekeeper approach, to ensure tracking of nodules and other abnormalities that are discovered during screening LDCT.”

  1. Yoon SH, Goldstein R, Jatil A, Arndt W, Haw SJ, et al. (2013, May). Abstract 29154: Low Dose CT Lung Cancer Screening Experience At A VA Medical Center. Presented at the ATS 2013 International Conference, Philadelphia, PA.

Comments are closed here.

Related Articles

Melanomas Associated With Internal Malignancy Risk

Genetic and environmental risk factors have been associated with the development of multiple primary melanomas (MPM) but a new study questioned whether those patients might have increased predisposition to developing internal malignancies.

Some RCC Risk Factors Can Be Modified

Obesity, hypertension and smoking are the three modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma, according to a new study.

U.S. Medicine Recommends

More From department of veterans affairs

Department of Veterans Affairs (VA)

Senate VA Committee Chair Vows to Pass 'Blue Water' Navy Benefits

Senate Committee on Veterans' Affairs Chairman Sen. Johnny Isakson (R-GA) vowed that addressing benefits for Blue Water Navy Veterans “is no longer going to be a question,” but that “how we do it is the only question.”

Department of Veterans Affairs (VA)

VHA Makes Progress in Improving Safety of Opioid Prescribing

VHA medical facilities should ensure that its providers are following three key opioid risk mitigation strategies, including conducting urine drug screening, a recent report recommended.

Department of Veterans Affairs (VA)

VA faces healthcare staffing shortages, barriers to hiring facility leaders

A facility-specific survey found that 138 of 140 VA facilities reported shortages of medical officers, with psychiatry and primary care positions being the most frequently listed.

Department of Veterans Affairs (VA)

Veteran nephrologist labors to improve ESRD treatment at VA

When Terrence O’Neil, MD, retired as chief of nephrology at the James H. Quillen VAMC in Johnson City in December 2016, he left in his wake decades of work treating kidney disease—nearly 35 years in the Air Force and DoD, plus 11 more at VA.

Department of Veterans Affairs (VA)

Committee approves bill to provide agent orange benefits to ‘blue water’ vets

A long sought-after bill that would make it easier for Blue Water Navy veterans to receive Agent Orange benefits has been passed by a key House of Representatives committee.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up